Monday, November 26, 2018

Oncogenesis - Table of Contents alert Volume 7, November 2018

Oncogenesis

TABLE OF CONTENTS

Volume 7 (November 2018)

In this issue
Article

Article

Top

IKKß activates p53 to promote cancer cell adaptation to glutamine deprivation

Mari B. Ishak Gabra, Ying Yang, Xazmin H. Lowman, Michael A. Reid, Thai Q. Tran et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0104-0

Abstract | Full Text

CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer

Lindsay J. Wheeler, Zachary L. Watson, Lubna Qamar, Tomomi M. Yamamoto, Miriam D. Post et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0103-1

Abstract | Full Text

Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness

Gi-Cheon Kim, Ho-Keun Kwon, Choong-Gu Lee, Ravi Verma, Dipayan Rudra et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0101-3

Abstract | Full Text

Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer

Linjun Wang, Jianghao Xu, Yiwen Xia, Kai Yin, Zheng Li et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0099-6

Abstract | Full Text

miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling

Shuai Xiao, Mengyuan Yang, Hao Yang, Ruimin Chang, Feng Fang et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0097-8

Abstract | Full Text

Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function

Xiao Xiang, Stéphanie Langlois, Marie-Eve St-Pierre, Jessica F. Barré, David Grynspan et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0100-4

Abstract | Full Text

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy

V. L. Veenstra, H. Damhofer, C. Waasdorp, L. B. van Rijssen, M. J. van de Vijver et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0096-9

Abstract | Full Text

Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo

Seung-Shick Shin, Byeong-Seon Jeong, Brian A. Wall, Jiadong Li, Naing Lin Shan et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0098-7

Abstract | Full Text

Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia

Zheng Ge, Qi Han, Yan Gu, Qinyu Ge, Jinlong Ma et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0095-x

Abstract | Full Text

Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways

Cheolwon Choi, Nguyen Thi Thao Tran, Trinh Van Ngu, Sae Woong Park, Min Suk Song et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0094-y

Abstract | Full Text

Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma

Wei Chen, Hao Zhang, Zhifeng Chen, Hao Jiang, Liping Liao et al.

Oncogenesis 2018 7: 10.1038/s41389-018-0093-z

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription.

This email has been sent to edgeblog.alerts.2011.001@gmail.com.

If you no longer wish to receive the email alerts from Oncogenesis click here to unsubscribe .
If you wish to discontinue all email services from Nature Research please click here to unsubscribe .

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature
 

No comments: